NF-kappaB signalling in chronic kidney disease

Frontiers in Bioscience

Volumn 14, Issue 9, 2009, Pages 3496-3522

  Rangan, Gopala ^a,b   Wang, Yiping ^a,b   Harris, David ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b University of Sydney   (Australia)

Author keywords

Chronic kidney disease; Human; Mice; Nuclear factor kappaB; Rats; Review; Therapy; Transcription factor

Indexed keywords

ANIMALIA; MAMMALIA; MUS; RATTUS;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL; CHRONIC KIDNEY FAILURE; DISEASE MODEL; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY FAILURE, CHRONIC; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 63849257554     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2735/3467     Document Type: Article

References (216)

1. Sen, R. & D. Baltimore: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 46, 705-16(1986) (Pubitemid 16020062)
2. Basseres, D. S. & A. S. Baldwin: Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene, 25, 6817-30(2006) (Pubitemid 44657854)
3. Gilmore, T. D.: Introduction to NF-kappaB: players, pathways, perspectives. Oncogene, 25, 6680-4(2006) (Pubitemid 44657845)
4. Wenzel, U. O. & R. A. Stahl: Chemokines, renal disease, and HIV infection. Nephron, 81, 5-16(1999) (Pubitemid 29041710)
5. Kelso, A.: The enigma of cytokine redundancy. Immunol Cell Biol, 72, 97-101(1994) (Pubitemid 24068053)
6. Sakurai, H., Y. Hisada, M. Ueno, M. Sugiura, K. Kawashima & T. Sugita: Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochim Biophys Acta, 1316, 132-8(1996) (Pubitemid 26193966)
7. Seto, M., S. Kim, H. Yoshifusa, Y. Nakamura, T. Masuda, A. Hamaguchi, S. Yamanaka & H. Iwao: Effects of prednisolone on glomerular signal transduction cascades in experimental glomerulonephritis. J Am Soc Nephrol, 9, 1367-76(1998) (Pubitemid 28354546)
8. Gomez-Garre, D., R. Largo, L. Soto, J. Tejera & J. Egido: Overload proteinuria elicits NF-kappaB activation in tubular epithelial cells, role of angiotensin II and endothelin-1. J Am Soc Nephrol, 9, 400A (1998)
9. Donadelli, R., M. Abbate, C. Zanchi, D. Corna, S. Tomasoni, A. Benigni, G. Remuzzi & C. Zoja: Protein traffic activates NF-kappaBgene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis, 36, 1226-41(2000)
10. Abbate, M., C. Zoja & G. Remuzzi: How does proteinuria cause progressive renal damage? J Am Soc Nephrol, 17, 2974-84(2006) (Pubitemid 44707757)
11. Guijarro, C. & J. Egido: Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int, 59, 415-24(2001) (Pubitemid 32157906)
12. Morrissey, J. & S. Klahr: Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction. Semin Nephrol, 18, 603-11(1998) (Pubitemid 28506732)
13. Wardle, E. N.: Nuclear factor kappaB for the nephrologist. Nephrol Dial Transplant, 16, 1764-8(2001)
14. Tamada, S., T. Asai, N. Kuwabara, T. Iwai, J. Uchida, K. Teramoto, N. Kaneda, T. Yukimura, T. Komiya, T. Nakatani & K. Miura: Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosis. J Pharmacol Sci, 100, 17-21(2006) (Pubitemid 43161609)
15. Chariot, A.: 20 years of NF-kappaB. Biochem Pharmacol, 72, 1051-3(2006)
16. Garber, K.: Patently absurd? Nat Biotechnol, 24, 737-9(2006) (Pubitemid 44086602)
17. Hoffmann, A., G. Natoli & G. Ghosh: Transcriptional regulation via the NF-kappaB signaling module. Oncogene, 25, 6706-16(2006) (Pubitemid 44657847)
18. Pahl, H. L.: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18, 6853-66(1999)
19. Tian, B., D. E. Nowak, M. Jamaluddin, S. Wang & A. R. Brasier: Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling. J Biol Chem, 280, 17435-48(2005) (Pubitemid 41389215)
20. Hoffmann, A. & D. Baltimore: Circuitry of nuclear factor kappaB signaling. Immunol Rev, 210, 171-86(2006)
21. Klement, J. F., N. R. Rice, B. D. Car, S. J. Abbondanzo, G. D. Powers, P. H. Bhatt, C. H. Chen, C. A. Rosen & C. L. Stewart: IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol, 16, 2341-9(1996) (Pubitemid 26123755)
22. Ghosh, S., M. J. May & E. B. Kopp: NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol, 16, 225-60(1998) (Pubitemid 28183365)
23. Chen, F., V. Castranova, X. Shi & L. M. Demers: New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem, 45, 7-17(1999) (Pubitemid 29036378)
24. Gerondakis, S., R. Grumont, R. Gugasyan, L. Wong, I. Isomura, W. Ho & A. Banerjee: Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene, 25, 6781-99(2006) (Pubitemid 44657852)
25. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh & D. Baltimore: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature, 376, 167-70(1995)
26. Doi, T. S., M. W. Marino, T. Takahashi, T. Yoshida, T. Sakakura, L. J. Old & Y. Obata: Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A, 96, 2994-9(1999) (Pubitemid 29148832)
27. Alcamo, E., J. P. Mizgerd, B. H. Horwitz, R. Bronson, A. A. Beg, M. Scott, C. M. Doerschuk, R. O. Hynes & D. Baltimore: Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol, 167, 1592-600(2001) (Pubitemid 32703160)
28. Dutta, J., Y. Fan, N. Gupta, G. Fan & C. Gelinas: Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene, 25, 6800-16(2006) (Pubitemid 44657853)
29. Zhang, J. Y., C. L. Green, S. Tao & P. A. Khavari: NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev, 18, 17-22(2004) (Pubitemid 38090684)
30. Hayden, M. S. & S. Ghosh: Signaling to NF-kappaB. Genes Dev, 18, 2195-224(2004)
31. Brunn, G. J., M. K. Bungum, G. B. Johnson & J. L. Platt: Conditional signaling by Toll-like receptor 4. Faseb J, 19, 872-4(2005) (Pubitemid 40617413)
32. Chae, S., L. Eckmann, Y. Miyamoto, C. Pothoulakis, M. Karin & M. F. Kagnoff: Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury. J Immunol, 177, 1214-20(2006) (Pubitemid 44036626)
33. Stein, B., A. S. Baldwin, Jr., D. W. Ballard, W. C. Greene, P. Angel & P. Herrlich: Cross-coupling of the NF-kappa B p65 and Fos/Jun. transcription factors produces potentiated biological function. Embo J, 12, 3879-91(1993) (Pubitemid 23282764)
34. Perkins, N. D.: Achieving transcriptional specificity with NF-kappa B. Int J Biochem Cell Biol, 29, 1433-48(1997)
35. Chen, L. F. & W. C. Greene: Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol, 5, 392-401(2004)
36. Starkey, J. M., S. J. Haidacher, W. S. LeJeune, X. Zhang, B. C. Tieu, S. Choudhary, A. R. Brasier, L. A. Denner & R. G. Tilton: Diabetes-induced activation of canonical and noncanonical nuclear factor-kappaB pathways in renal cortex. Diabetes, 55, 1252-9(2006) (Pubitemid 44195361)
37. Liang, M., A. W. Cowley, Jr., M. J. Hessner, J. Lazar, D. P. Basile & J. L. Pietrusz: Transcriptome analysis and kidney research: toward systems biology. Kidney Int, 67, 2114-22(2005) (Pubitemid 41623373)
38. Maier, H. J., R. Marienfeld, T. Wirth & B. Baumann: Critical role of RelB serine 368 for dimerization and p100 stabilization. J Biol Chem, 278, 39242-50(2003) (Pubitemid 37221828)
39. Huxford, T., D. Mishler, C. B. Phelps, D. B. Huang, L. L. Sengchanthalangsy, R. Reeves, C. A. Hughes, E. A. Komives & G. Ghosh: Solvent exposed non-contacting amino acids play a critical role in NF-kappaB/IkappaBalpha complex formation. J Mol Biol, 324, 587-97(2002) (Pubitemid 36044099)
40. Ghosh, G., D. B. Huang & T. Huxford: Molecular mimicry of the NF-kappaB DNA target site by a selected RNA aptamer. Curr Opin Struct Biol, 14, 21-7(2004) (Pubitemid 38249588)
41. Isomura, I. & A. Morita: Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides. Microbiol Immunol, 50, 559-63(2006) (Pubitemid 44285282)
42. Magness, S. T., H. Jijon, N. Van Houten Fisher, N. E. Sharpless, D. A. Brenner & C. Jobin: In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol, 173, 1561-70(2004) (Pubitemid 38971585)
43. Karin, M.: How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene, 18, 6867-74(1999)
44. Perkins, N. D. & T. D. Gilmore: Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ, 13, 759-72(2006)
45. Seitz, C. S., Q. Lin, H. Deng & P. A. Khavari: Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc Natl Acad Sci U S A, 95, 2307-12(1998) (Pubitemid 28145937)
46. Watanabe, Y., M. Tamura, A. Osajima, H. Anai, N. Kabashima, R. Serino & Y. Nakashima: Integrins induce expression of monocyte chemoattractant protein-1 via focal adhesion kinase in mesangial cells. Kidney Int, 64, 431-40(2003) (Pubitemid 36871914)
47. Morigi, M., D. Macconi, C. Zoja, R. Donadelli, S. Buelli, C. Zanchi, M. Ghilardi & G. Remuzzi: Protein overload-induced NF-kappaB activation in proximal tubular cells requires H (2) O (2) through a PKC-dependent pathway. J Am Soc Nephrol, 13, 1179-89(2002) (Pubitemid 34441398)
48. Pippin, J. W., R. Durvasula, A. Petermann, K. Hiromura, W. G. Couser & S. J. Shankland: DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest, 111, 877-85(2003) (Pubitemid 37074963)
49. Li, X. C. & J. L. Zhuo: Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Curr Opin Nephrol Hypertens, 17, 37-43(2008) (Pubitemid 350295195)
50. Ruiz-Ortega, M., M. Ruperez, V. Esteban, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal & J. Egido: Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant, 21, 16-20(2006) (Pubitemid 43057101)
51. Zhuo, J. L., O. A. Carretero & X. C. Li: Effects of AT1 receptor-mediated endocytosis of extracellular Ang II on activation of nuclear factor-kappa B in proximal tubule cells. Ann N y Acad Sci, 1091, 336-45(2006) (Pubitemid 47092248)
52. Yu, C., R. Gong, A. Rifai, E. M. Tolbert & L. D. Dworkin: Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection. J Am Soc Nephrol, 18, 750-9(2007) (Pubitemid 46434492)
53. Esteban, V., O. Lorenzo, M. Ruperez, Y. Suzuki, S. Mezzano, J. Blanco, M. Kretzler, T. Sugaya, J. Egido & M. Ruiz-Ortega: Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol, 15, 1514-29(2004) (Pubitemid 38679676)
54. Okada, H., T. Inoue, T. Kikuta, Y. Watanabe, Y. Kanno, S. Ban, T. Sugaya, M. Horiuchi & H. Suzuki: A possible antiinflammatory role of angiotensin II type 2 receptor in immunemediated glomerulonephritis during type 1 receptor blockade. Am J Pathol, 169, 1577-89(2006) (Pubitemid 351181990)
55. Anders, H. J. & D. Schlondorff: Toll-like receptors: emerging concepts in kidney disease. Curr Opin Nephrol Hypertens, 16, 177-83(2007) (Pubitemid 46608524)
56. Kawai, T. & S. Akira: Signaling to NF-kappaB by Tolllike receptors. Trends Mol Med (2007)
57. Kanzler, H., F. J. Barrat, E. M. Hessel & R. L. Coffman: Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med, 13, 552-9(2007) (Pubitemid 46830615)
58. Patole, P. S., R. D. Pawar, J. Lichtnekert, M. Lech, O. P. Kulkarni, A. Ramanjaneyulu, S. Segerer & H. J. Anders: Coactivation of Toll-like receptor-3 and-7 in immune complex glomerulonephritis. J Autoimmun, 29, 52-9(2007) (Pubitemid 47016916)
59. Tsuboi, N., Y. Yoshikai, S. Matsuo, T. Kikuchi, K. Iwami, Y. Nagai, O. Takeuchi, S. Akira & T. Matsuguchi: Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol, 169, 2026-33(2002) (Pubitemid 34857667)
60. Benigni, A., C. Caroli, L. Longaretti, E. Gagliardini, C. Zoja, M. Galbusera, D. Moioli, P. Romagnani, A. Tincani, L. Andreoli & G. Remuzzi: Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. Arthritis Rheum, 56, 1569-78(2007) (Pubitemid 46764086)
61. Patole, P. S., R. D. Pawar, M. Lech, D. Zecher, H. Schmidt, S. Segerer, A. Ellwart, A. Henger, M. Kretzler & H. J. Anders: Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas (lpr) mice. Nephrol Dial Transplant, 21, 3062-73(2006) (Pubitemid 44567076)
62. Pawar, R. D., A. Ramanjaneyulu, O. P. Kulkarni, M. Lech, S. Segerer & H. J. Anders: Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol, 18, 1721-31(2007) (Pubitemid 46870309)
63. Wu, H., G. Chen, K. R. Wyburn, J. Yin, P. Bertolino, J. M. Eris, S. I. Alexander, A. F. Sharland & S. J. Chadban: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest, 117, 2847-59(2007) (Pubitemid 47529615)
64. Delhase, M., M. Hayakawa, Y. Chen & M. Karin: Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science, 284, 309-13(1999)
65. Yamada, M., S. Katsuma, T. Adachi, A. Hirasawa, S. Shiojima, T. Kadowaki, Y. Okuno, T. A. Koshimizu, S. Fujii, Y. Sekiya, Y. Miyamoto, M. Tamura, W. Yumura, H. Nihei, M. Kobayashi & G. Tsujimoto: Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. Proc Natl Acad Sci U S A, 102, 7736-41(2005) (Pubitemid 40741040)
66. Wang, X. W., N. S. Tan, B. Ho & J. L. Ding: Evidence for the ancient origin of the NF-kappaB/IkappaB cascade: its archaic role in pathogen infection and immunity. Proc Natl Acad Sci U S A, 103, 4204-9(2006)
67. Ito, C. Y., N. Adey, V. L. Bautch & A. S. Baldwin, Jr.: Structure and evolution of the human IKBA gene. Genomics, 29, 490-5(1995)
68. Rupec, R. A., D. Poujol, J. Grosgeorge, G. F. Carle, A. Livolsi, J. F. Peyron, R. M. Schmid, P. A. Baeuerle & G. Messer: Structural analysis, expression, and chromosomal localization of the mouse ikba gene. Immunogenetics, 49, 395-403(1999) (Pubitemid 29178822)
69. Carlsen, H., J. O. Moskaug, S. H. Fromm & R. Blomhoff: In vivo imaging of NF-kappa B activity. J Immunol, 168, 1441-6(2002)
70. Levine, M. & R. Tjian: Transcription regulation and animal diversity. Nature, 424, 147-51(2003) (Pubitemid 36858677)
71. Brenner, S.: Nobel lecture. Nature's gift to science. Biosci Rep, 23, 225-37(2003)
72. Gerritsma, J. S., C. van Kooten, A. F. Gerritsen, L. A. van Es & M. R. Daha: Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int, 53, 609-16(1998) (Pubitemid 28124274)
73. Kuroiwa, T., R. Schlimgen, G. G. Illei, I. B. McInnes & D. T. Boumpas: Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: implications for tubulointerstitial injury in chronic glomerulonephritides. J Immunol, 164, 3323-9(2000) (Pubitemid 30148997)
74. Latchman, D. S.: Transcription factors: an overview. Int J Biochem Cell Biol, 29, 1305-12(1997) (Pubitemid 28153484)
75. Roebuck, K. A., L. R. Carpenter, V. Lakshminarayanan, S. M. Page, J. N. Moy & L. L. Thomas: Stimulus-specific regulation of chemokine expression involves differential activation of the redoxresponsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol, 65, 291-8(1999) (Pubitemid 29109699)
76. Jongeneel, C. V.: Regulation of the TNF alpha gene. Prog Clin Biol Res, 388, 367-81(1994)
77. Zhong, H., R. E. Voll & S. Ghosh: Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell, 1, 661-71(1998) (Pubitemid 128379244)
78. Wang, D. & A. S. Baldwin, Jr.: Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J Biol Chem, 273, 29411-6(1998) (Pubitemid 28509943)
79. Shin, M., Y. Hishikawa, S. Izumi & T. Koji: Southwestern histochemistry as a molecular histochemical tool for analysis of expression of transcription factors: application to paraffin-embedded tissue sections. Med Electron Microsc, 35, 217-24(2002) (Pubitemid 36205681)
80. Sakai, N., T. Wada, K. Furuichi, Y. Iwata, K. Yoshimoto, K. Kitagawa, S. Kokubo, M. Kobayashi, A. Hara, J. Yamahana, T. Okumura, K. Takasawa, S. Takeda, M. Yoshimura, H. Kida & H. Yokoyama: Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis, 45, 54-65(2005) (Pubitemid 40038045)
81. Zheng, L., R. Sinniah & S. I. Hsu: In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy. Virchows Arch, 448, 172-83(2006) (Pubitemid 43237883)
82. Mezzano, S. A., M. Barria, M. A. Droguett, M. E. Burgos, L. G. Ardiles, C. Flores & J. Egido: Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int, 60, 1366-77(2001) (Pubitemid 32960030)
83. Mezzano, S., A. Droguett, M. E. Burgos, L. G. Ardiles, C. A. Flores, C. A. Aros, I. Caorsi, C. P. Vio, M. Ruiz-Ortega & J. Egido: Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int SupplS 64-70 (2003)
84. Mezzano, S., C. Aros, A. Droguett, M. E. Burgos, L. Ardiles, C. Flores, H. Schneider, M. Ruiz-Ortega & J. Egido: NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant, 19, 2505-12(2004) (Pubitemid 39360096)
85. Morcos, M., A. A. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, H. Tritschler, M. Kasper, V. Schwenger, A. Hamann, K. A. Dugi, A. M. Schmidt, D. Stern, R. Ziegler, H. U. Haering, M. Andrassy, F. van der Woude & P. P. Nawroth: Activation of tubular epithelial cells in diabetic nephropathy. Diabetes, 51, 3532-44(2002) (Pubitemid 35403461)
86. Schmid, H., A. Boucherot, Y. Yasuda, A. Henger, B. Brunner, F. Eichinger, A. Nitsche, E. Kiss, M. Bleich, H. J. Grone, P. J. Nelson, D. Schlondorff, C. D. Cohen & M. Kretzler: Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes, 55, 2993-3003(2006) (Pubitemid 44923635)
87. Hofmann, M. A., S. Schiekofer, B. Isermann, M. Kanitz, M. Henkels, M. Joswig, A. Treusch, M. Morcos, T. Weiss, V. Borcea, A. K. Abdel Khalek, J. Amiral, H. Tritschler, E. Ritz, P. Wahl, R. Ziegler, A. Bierhaus & P. P. Nawroth: Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia, 42, 222-32(1999) (Pubitemid 29064245)
88. Hofmann, M. A., S. Schiekofer, M. Kanitz, M. S. Klevesath, M. Joswig, V. Lee, M. Morcos, H. Tritschler, R. Ziegler, P. Wahl, A. Bierhaus & P. P. Nawroth: Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care, 21, 1310-6(1998) (Pubitemid 28365689)
89. Cipollone, F., F. Chiarelli, A. Iezzi, M. L. Fazia, C. Cuccurullo, B. Pini, D. de Cesare, M. Torello, S. Tumini, F. Cuccurullo & A. Mezzetti: Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. Int J Immunopathol Pharmacol, 18, 625-35(2005)
90. Hunley, T. E., A. Fogo, S. Iwasaki & V. Kon: Endothelin A receptor mediates functional but not structural damage in chronic cyclosporine nephrotoxicity. J Am Soc Nephrol, 5, 1718-23(1995)
91. Fogo, A. B.: Mechanisms of progression of chronic kidney disease. Pediatr Nephrol, 22, 2011-22(2007) (Pubitemid 50001040)
92. Romzova, M., D. Hohenadel, K. Kolostova, D. Pinterova, M. Fojtikova, S. Ruzickova, C. Dostal, V. Bosak, I. Rychlik & M. Cerna: NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications. Hum Immunol, 67, 706-13(2006) (Pubitemid 44430108)
93. Lin, H. Y., C. L. Wang, P. J. Hsiao, Y. C. Lu, S. Y. Chen, K. D. Lin, S. C. Hsin, M. C. Hsieh & S. J. Shin: SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes. Diabetes, 56, 1177-80(2007)
94. Ashizawa, M., M. Miyazaki, K. Abe, A. Furusu, H. Isomoto, T. Harada, Y. Ozono, H. Sakai, T. Koji & S. Kohno: Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry. Am J Kidney Dis, 42, 76-86(2003) (Pubitemid 36813986)
95. Hong, S. W., H. J. Jeong, Y. S. Kim, S. I. Kim, K. H. Choi, H. Y. Lee, D. S. Han & K. Park: Nuclear factor kappa B activation in glomeruli of posttransplant IgA nephropathy using southwestern histochemistry. Transplant Proc, 35, 179-80(2003) (Pubitemid 36194563)
96. Sakai, N., T. Wada, K. Furuichi, Y. Iwata, K. Yoshimoto, K. Kitagawa, S. Kokubo, M. Kobayashi, S. Takeda, H. Kida, K. Kobayashi, N. Mukaida, K. Matsushima & H. Yokoyama: p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transplant, 17, 998-1004(2002) (Pubitemid 34746201)
97. Zheng, L., R. Sinniah & I. H. H. S: Renal cell apoptosis and proliferation may be linked to nuclear factor-kappaB activation and expression of inducible nitric oxide synthase in patients with lupus nephritis. Hum Pathol, 37, 637-47(2006) (Pubitemid 43956530)
98. Meyer, T. W. & T. H. Hostetter: Uremia. N Engl J Med, 357, 1316-25(2007)
99. Bierhaus, A., P. M. Humpert & P. P. Nawroth: NF-kappaB as a molecular link between psychosocial stress and organ dysfunction. Pediatr Nephrol, 19, 1189-91(2004) (Pubitemid 39462418)
100. Rodriguez-Ayala, E., B. Anderstam, M. E. Suliman, A. Seeberger, O. Heimburger, B. Lindholm & P. Stenvinkel: Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients. Atherosclerosis, 180, 333-40(2005) (Pubitemid 41072904)
101. Rangan, G. K., G. Kan, J. H. Steer, G. Dogra, K. D. Croft, H. C. Rhodes, A. J. Woodroffe & D. A. Joyce: Altered expression of nuclear factor-kappaB in peripheral blood mononuclear cells in chronic haemodialysis patients. Nephrol Dial Transplant, 21, 1137-9(2006)
102. Rennke, H. G. & P. S. Klein: Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis, 13, 443-56(1989) (Pubitemid 19160779)
103. Shankland, S. J.: The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int, 69, 2131-47(2006) (Pubitemid 43882099)
104. Morigi, M., S. Buelli, C. Zanchi, L. Longaretti, D. Macconi, A. Benigni, D. Moioli, G. Remuzzi & C. Zoja: Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol, 169, 1965-75(2006) (Pubitemid 351181958)
105. Morigi, M., S. Buelli, S. Angioletti, C. Zanchi, L. Longaretti, C. Zoja, M. Galbusera, S. Gastoldi, P. Mundel, G. Remuzzi & A. Benigni: In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am J Pathol, 166, 1309-20(2005) (Pubitemid 40586503)
106. Greiber, S., B. Muller, P. Daemisch & H. Pavenstadt: Reactive oxygen species alter gene expression in podocytes: induction of granulocyte macrophage-colonystimulating factor. J Am Soc Nephrol, 13, 86-95(2002) (Pubitemid 34042015)
107. Bondeva, T., T. Roger & G. Wolf: Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites. Am J Nephrol, 27, 308-14(2007) (Pubitemid 47164681)
108. Gu, L., S. Hagiwara, Q. Fan, M. Tanimoto, M. Kobata, M. Yamashita, T. Nishitani, T. Gohda, Z. Ni, J. Qian, S. Horikoshi & Y. Tomino: Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. Nephrol Dial Transplant, 21, 299-313(2006) (Pubitemid 43159982)
109. Gu, L., Z. Ni, J. Qian & Y. Tomino: Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signalling events. Nephron Exp Nephrol, 106, e-110 (2007)
110. Szabo, C., A. Biser, R. Benko, E. Bottinger & K. Susztak: Poly (ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes, 55, 3004-12(2006) (Pubitemid 44923636)
111. Schiffer, M., M. Bitzer, I. S. Roberts, J. B. Kopp, P. ten Dijke, P. Mundel & E. P. Bottinger: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest, 108, 807-16(2001) (Pubitemid 32880291)
112. Bruggeman, L. A., S. H. Adler & P. E. Klotman: Nuclear factor-kappa B binding to the HIV-1 LTR in kidney: implications for HIV-associated nephropathy. Kidney Int, 59, 2174-81(2001) (Pubitemid 32467609)
113. Martinka, S. & L. A. Bruggeman: Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy. Am J Physiol Renal Physiol, 290, F657-65 (2006) (Pubitemid 43724968)
114. Ross, M. J., S. Martinka, V. D. D'Agati & L. A. Bruggeman: NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J Am Soc Nephrol, 16, 2403-11(2005) (Pubitemid 41725058)
115. Haneda, M., D. Koya, M. Isono & R. Kikkawa: Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol, 14, 1374-82(2003) (Pubitemid 36514677)
116. Gomez-Guerrero, C., Y. Suzuki & J. Egido: The identification of IgA receptors in human mesangial cells: in the search for "Eldorado". Kidney Int, 62, 715-7(2002) (Pubitemid 34779785)
117. Massy, Z. A., C. Guijarro, M. P. O'Donnell, Y. Kim, C. E. Kashtan, J. Egido, B. L. Kasiske & W. F. Keane: The central role of nuclear factor-kappa B in mesangial cell activation. Kidney Int Suppl, 71, S76-9 (1999) (Pubitemid 29304819)
118. Stylianou, E., M. Nie, A. Ueda & L. Zhao: c-Rel and p65 trans-activate the monocyte chemoattractant protein-1 gene in interleukin-1 stimulated mesangial cells. Kidney Int, 56, 873-82(1999) (Pubitemid 29411715)
119. Grassl, C., B. Luckow, D. Schlondorff & U. Dendorfer: Transcriptional regulation of the interleukin-6 gene in mesangial cells. J Am Soc Nephrol, 10, 1466-77(1999) (Pubitemid 29297521)
120. Lucio-Cazana, J., K. Nakayama, Q. Xu, T. Konta, V. Moreno-Manzano, A. Furusu & M. Kitamura: Suppression of constitutive but not Il-1beta-inducible expression of monocyte chemoattractant protein-1 in mesangial cells by retinoic acids: intervention in the activator protein-1 pathway. J Am Soc Nephrol, 12, 688-94(2001) (Pubitemid 32246696)
121. Satriano, J. & D. Schlondorff: Activation and attenuation of transcription factor NF-kappaBin mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3':5'-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J Clin Invest, 94, 1629-36(1994)
122. Rovin, B. H., J. A. Dickerson, L. C. Tan & C. A. Hebert: Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells. Kidney Int, 48, 1263-71(1995)
123. Ruiz-Ortega, M., C. Bustos, M. A. Hernandez-Presa, O. Lorenzo, J. J. Plaza & J. Egido: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol, 161, 430-9(1998) (Pubitemid 28285552)
124. Ingram, A. J., L. James, K. Thai, H. Ly, L. Cai & J. W. Scholey: Nitric oxide modulates mechanical straininduced activation of p38 MAPK in mesangial cells. Am J Physiol Renal Physiol, 279, F243-51 (2000)
125. Park, C. W., J. H. Kim, J. H. Lee, Y. S. Kim, H. J. Ahn, Y. S. Shin, S. Y. Kim, E. J. Choi, Y. S. Chang & B. K. Bang: High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent. Diabetologia, 43, 1544-53(2000) (Pubitemid 32734862)
126. Russell, W. J., J. Cardelli, E. Harris, R. J. Baier & G. A. Herrera: Monoclonal light chain-mesangial cell interactions: early signaling events and subsequent pathologic effects. Lab Invest, 81, 689-703(2001) (Pubitemid 32466532)
127. Tanaka, T., T. Kuroiwa, H. Ikeuchi, F. Ota, Y. Kaneko, K. Ueki, Y. Tsukada, I. B. McInnes, D. T. Boumpas & Y. Nojima: Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury. J Am Soc Nephrol, 13, 2488-96(2002)
128. Chang, P. C., T. H. Chen, C. J. Chang, C. C. Hou, P. Chan & H. M. Lee: Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway. Kidney Int, 65, 1664-75(2004) (Pubitemid 38591014)
129. Chang, J. W., C. S. Kim, S. B. Kim, S. K. Park, J. S. Park & S. K. Lee: C-reactive protein induces NF-kappaB activation through intracellular calcium and ROS in human mesangial cells. Nephron Exp Nephrol, 101, e-16572 (2005)
130. Cheng, J., M. M. Diaz Encarnacion, G. M. Warner, C. E. Gray, K. A. Nath & J. P. Grande: TGF-beta1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process. Am J Physiol Cell Physiol, 289, C-95970 (2005)
131. Hayakawa, K., Y. Meng, N. Hiramatsu, A. Kasai, K. Yamauchi, J. Yao & M. Kitamura: Priming of glomerular mesangial cells by activated macrophages causes blunted responses to proinflammatory stimuli. J Immunol, 176, 2529-37(2006) (Pubitemid 43201704)
132. Qing, X., J. Zavadil, M. B. Crosby, M. P. Hogarth, B. H. Hahn, C. Mohan, G. S. Gilkeson, E. P. Bottinger & C. Putterman: Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum, 54, 2198-210(2006) (Pubitemid 44051076)
133. Rovin, B. H. & H. Song: Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin Immunol, 120, 99-105(2006) (Pubitemid 43903386)
134. Duque, N., C. Gomez-Guerrero & J. Egido: Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factorkappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol, 159, 3474-82(1997) (Pubitemid 127482106)
135. Terada, Y., H. Kuwana, T. Kobayashi, T. Okado, N. Suzuki, T. Yoshimoto, Y. Hirata & S. Sasaki: Aldosteronestimulated SGK1 activity mediates profibrotic signaling in the mesangium. J Am Soc Nephrol, 19, 298-309(2008) (Pubitemid 351240652)
136. Yokoo, T. & M. Kitamura: Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am J Physiol, 270, F123-30 (1996)
137. Sheu, M. L., K. F. Chao, Y. J. Sung, W. W. Lin, S. Y. Lin-Shiau & S. H. Liu: Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells. Cell Signal, 17, 975-84(2005)
138. Khera, T., J. Martin, S. Riley, R. Steadman & A. O. Phillips: Glucose enhances mesangial cell apoptosis. Lab Invest, 86, 566-77(2006) (Pubitemid 43780438)
139. Maruyama, K., N. Kashihara, Y. Yamasaki, M. Sato, H. Sugiyama, K. Okamoto, Y. Maeshima, M. Odawara, J. Sasaki & H. Makino: Methylprednisolone accelerates the resolution of glomerulonephritis by sensitizing mesangial cells to apoptosis. Exp Nephrol, 9, 317-26(2001) (Pubitemid 32830564)
140. Johnson, R. J.: What mediates progressive glomerulosclerosis? The glomerular endothelium comes of age. Am J Pathol, 151, 1179-81(1997)
141. Messmer, U. K., V. A. Briner & J. Pfeilschifter: Basic fibroblast growth factor selectively enhances TNF-alphainduced apoptotic cell death in glomerular endothelial cells: effects on apoptotic signaling pathways. J Am Soc Nephrol, 11, 2199-211(2000)
142. Zoja, C., S. Angioletti, R. Donadelli, C. Zanchi, S. Tomasoni, E. Binda, B. Imberti, M. te Loo, L. Monnens, G. Remuzzi & M. Morigi: Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int, 62, 846-56(2002) (Pubitemid 35316713)
143. Eng, E. & B. J. Ballermann: Diminished NF-kappaB activation and PDGF-B expression in glomerular endothelial cells subjected to chronic shear stress. Microvasc Res, 65, 137-44(2003) (Pubitemid 36438679)
144. Ohse, T., J. Pippin, M. Vaughan & S. J. Shankland: Establishing immortalized mouse parietal epithelial cells in culture. J Am Soc Nephrol (2007)
145. Rangan, G. K., Y. Wang, Y. C. Tay & D. C. Harris: Inhibition of NFkappaB activation with antioxidants is correlated with reduced cytokine transcription in PTC. Am J Physiol, 277, F779-89 (1999)
146. Zoja, C., R. Donadelli, S. Colleoni, M. Figliuzzi, S. Bonazzola, M. Morigi & G. Remuzzi: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int, 53, 1608-15(1998) (Pubitemid 28243743)
147. Wang, Y., G. K. Rangan, Y. C. Tay, Y. Wang & D. C. Harris: Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol, 10, 1204-13(1999) (Pubitemid 29246985)
148. Gomez-Garre, D., R. Largo, N. Tejera, J. Fortes, F. Manzarbeitia & J. Egido: Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension, 37, 1171-8(2001) (Pubitemid 32304021)
149. Zafiriou, S., S. R. Stanners, T. S. Polhill, P. Poronnik & C. A. Pollock: Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses. Kidney Int, 65, 1647-53(2004) (Pubitemid 38591012)
150. Pahl, H. L.: Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol Rev, 79, 683-701(1999) (Pubitemid 29330171)
151. Ferreira, V., K. W. van Dijk, A. K. Groen, R. M. Vos, J. van der Kaa, M. J. Gijbels, L. M. Havekes & H. Pannekoek: Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation. Atherosclerosis, 192, 283-90(2007) (Pubitemid 46726329)
152. Tanifuji, C., Y. Suzuki, W. M. Geot, S. Horikoshi, T. Sugaya, M. Ruiz-Ortega, J. Egido & Y. Tomino: Reactive oxygen species-mediated signaling pathways in angiotensin II-induced MCP-1 expression of proximal tubular cells. Antioxid Redox Signal, 7, 1261-8(2005) (Pubitemid 41232523)
153. Tang, S. C., J. C. Leung, L. Y. Chan, A. W. Tsang & K. N. Lai: Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferatoractivated receptor-gamma agonist. J Am Soc Nephrol, 17, 1633-43(2006) (Pubitemid 43794666)
154. Panchapakesan, U., S. Sumual, C. A. Pollock & X. Chen: PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol, 289, F1153-8 (2005) (Pubitemid 41447072)
155. Li, X., H. Kimura, K. Hirota, K. Kasuno, K. Torii, T. Okada, H. Kurooka, Y. Yokota & H. Yoshida: Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells. Kidney Int, 68, 569-83(2005) (Pubitemid 43323112)
156. Pontrelli, P., M. Ursi, E. Ranieri, C. Capobianco, F. P. Schena, L. Gesualdo & G. Grandaliano: CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. J Am Soc Nephrol, 17, 627-36(2006)
157. Oertli, B., B. Beck-Schimmer, X. Fan & R. P. Wuthrich: Mechanisms of hyaluronan-induced upregulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kappa B and activating protein-1. J Immunol, 161, 3431-7(1998)
158. Wang, Y., G. K. Rangan, B. Goodwin, Y. C. Tay & D. C. Harris: Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factorkappaB dependent. Kidney Int, 57, 2011-22(2000) (Pubitemid 30252293)
159. Kapasi, A., P. Bhat & P. C. Singhal: Tubular cell and HIV-1 gp120 interaction products promote migration of monocytes. Inflammation, 22, 137-44(1998) (Pubitemid 28177172)
160. Yang, C. W., M. S. Wu, M. J. Pan, J. J. Hong, C. C. Yu, A. Vandewalle & C. C. Huang: Leptospira outer membrane protein activates NF-kappaB and downstream genes expressed in medullary thick ascending limb cells. J Am Soc Nephrol, 11, 2017-26(2000)
161. Thevenod, F., J. M. Friedmann, A. D. Katsen & I. A. Hauser: Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium-and reactive oxygen species-induced apoptosis. J Biol Chem, 275, 1887-96(2000) (Pubitemid 30060813)
162. Nadasdy, T., Z. Laszik, K. E. Blick, D. L. Johnson & F. G. Silva: Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study. Hum Pathol, 25, 22-8(1994) (Pubitemid 24051820)
163. Zhou, X., S. Doi & A. H. Iwagaki, P. Inactivation of NF-kappaB potentiates TNF-alpha-induced cytotoxicity in a renal proximal tubular cell line (abstract). J Am Soc Nephrol 9, (1998)
164. Chen, C. H., H. Lin, Y. H. Hsu, Y. M. Sue, T. H. Cheng, P. Chan & T. H. Chen: The protective effect of prostacyclin on adriamycin-induced apoptosis in rat renal tubular cells. Eur J Pharmacol, 529, 8-15(2006) (Pubitemid 43005279)
165. Laxmanan, S., D. Datta, C. Geehan, D. M. Briscoe & S. Pal: CD40: a mediator of pro-and anti-inflammatory signals in renal tubular epithelial cells. J Am Soc Nephrol, 16, 2714-23(2005)
166. Haussler, U., G. von Wichert, R. M. Schmid, F. Keller & G. Schneider: Epidermal growth factor activates nuclear factor-kappaB in human proximal tubule cells. Am J Physiol Renal Physiol, 289, F808-15 (2005) (Pubitemid 41324202)
167. Neilson, E. G.: Mechanisms of disease: Fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol, 2, 101-8(2006) (Pubitemid 43355218)
168. Wynn, T. A.: Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest, 117, 524-9(2007) (Pubitemid 46348506)
169. Scotton, C. J. & R. C. Chambers: Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest, 132, 1311-21(2007) (Pubitemid 47621009)
170. Iwano, M., D. Plieth, T. M. Danoff, C. Xue, H. Okada & E. G. Neilson: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest, 110, 341-50(2002) (Pubitemid 34847966)
171. Wada, T., N. Sakai, K. Matsushima & S. Kaneko: Fibrocytes: a new insight into kidney fibrosis. Kidney Int, 72, 269-73(2007) (Pubitemid 47172378)
172. Elsharkawy, A. M. & D. A. Mann: Nuclear factorkappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology, 46, 590-7(2007) (Pubitemid 47344795)
173. Klahr, S. & J. J. Morrissey: Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int Suppl, 63, S111-4 (1997) (Pubitemid 28020447)
174. Guo, G., J. Morrissey, R. McCracken, T. Tolley & S. Klahr: Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol, 277, F766-72 (1999)
175. Kuang, P. P., J. L. Berk, D. C. Rishikof, J. A. Foster, D. E. Humphries, D. A. Ricupero & R. H. Goldstein: NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype. Am J Physiol Cell Physiol, 283, C58-65 (2002) (Pubitemid 34670548)
176. Gallois, C., A. Habib, J. Tao, S. Moulin, J. Maclouf, A. Mallat & S. Lotersztajn: Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem, 273, 23183-90(1998) (Pubitemid 28417502)
177. Mudge, S. J., K. Paizis, R. B. Auwardt, R. J. Thomas & D. A. Power: Activation of nuclear factor-kappa B by podocytes in the autologous phase of passive Heymann nephritis. Kidney Int, 59, 923-31(2001) (Pubitemid 32206855)
178. Reiser, J., G. von Gersdorff, M. Loos, J. Oh, K. Asanuma, L. Giardino, M. P. Rastaldi, N. Calvaresi, H. Watanabe, K. Schwarz, C. Faul, M. Kretzler, A. Davidson, H. Sugimoto, R. Kalluri, A. H. Sharpe, J. A. Kreidberg & P. Mundel: Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest, 113, 1390-7(2004) (Pubitemid 39071694)
179. Shibata, S., M. Nagase & T. Fujita: Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling. J Am Soc Nephrol, 17, 754-64(2006)
180. Rangan, G. K., Y. Wang, Y. C. Tay & D. C. Harris: Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney Int, 56, 118-34(1999) (Pubitemid 29300527)
181. Henke, N., R. Schmidt-Ullrich, R. Dechend, J. K. Park, F. Qadri, M. Wellner, M. Obst, V. Gross, R. Dietz, F. C. Luft, C. Scheidereit & D. N. Muller: Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circ Res, 101, 268-76(2007) (Pubitemid 47344076)
182. Fujihara, C. K., G. R. Antunes, A. L. Mattar, D. M. Malheiros, J. M. Vieira, Jr. & R. Zatz: Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model. Am J Physiol Renal Physiol, 292, F92-9 (2007) (Pubitemid 46105247)
183. Morrissey, J. J. & S. Klahr: Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int, 52, 926-33(1997) (Pubitemid 27435825)
184. Satoh, M., N. Kashihara, Y. Yamasaki, K. Maruyama, K. Okamoto, Y. Maeshima, H. Sugiyama, T. Sugaya, K. Murakami & H. Makino: Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol, 12, 317-25(2001) (Pubitemid 32116373)
185. Lopez-Franco, O., Y. Suzuki, G. Sanjuan, J. Blanco, P. Hernandez-Vargas, Y. Yo, J. Kopp, J. Egido & C. Gomez-Guerrero: Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol, 161, 1497-505(2002)
186. Klahr, S.: Obstructive nephropathy. Intern Med, 39, 355-61(2000) (Pubitemid 30422100)
187. Vos, I. H., R. Govers, H. J. Grone, L. Kleij, M. Schurink, R. A. de Weger, R. Goldschmeding & T. J. Rabelink: NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. Faseb J, 14, 815-22(2000) (Pubitemid 30198580)
188. Tomita, N., R. Morishita, H. Y. Lan, K. Yamamoto, M. Hashizume, M. Notake, K. Toyosawa, B. Fujitani, W. Mu, D. J. Nikolic-Paterson, R. C. Atkins, Y. Kaneda, J. Higaki & T. Ogihara: In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol, 11, 1244-52(2000) (Pubitemid 30416220)
189. Takase, O., J. Hirahashi, A. Takayanagi, A. Chikaraishi, T. Marumo, Y. Ozawa, M. Hayashi, N. Shimizu & T. Saruta: Gene transfer of truncated IkappaBalpha prevents tubulointerstitial injury. Kidney Int, 63, 501-13(2003) (Pubitemid 36126796)
190. Heckmann, A., C. Waltzinger, P. Jolicoeur, M. Dreano, M. H. Kosco-Vilbois & Y. Sagot: IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS. Am J Pathol, 164, 1253-62(2004) (Pubitemid 38387792)
191. Wilson, H. M., S. Chettibi, C. Jobin, D. Walbaum, A. J. Rees & D. C. Kluth: Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol, 167, 27-37(2005) (Pubitemid 40884767)
192. Ka, S. M., X. R. Huang, H. Y. Lan, P. Y. Tsai, S. M. Yang, H. A. Shui & A. Chen: Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol, 18, 1777-88(2007) (Pubitemid 46870314)
193. Ng, Y. Y., C. C. Hou, W. Wang, X. R. Huang & H. Y. Lan: Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl S83-91 (2005)
194. Oakley, F., M. Meso, J. P. Iredale, K. Green, C. J. Marek, X. Zhou, M. J. May, H. Millward-Sadler, M. C. Wright & D. A. Mann: Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology, 128, 108-20(2005) (Pubitemid 40039963)
195. Oakley, F., J. Mann, S. Nailard, D. E. Smart, N. Mungalsingh, C. Constandinou, S. Ali, S. J. Wilson, H. Millward-Sadler, J. P. Iredale & D. A. Mann: Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol, 166, 695-708(2005) (Pubitemid 40315627)
196. Gilmore, T. D. & M. Herscovitch: Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene, 25, 6887-99(2006) (Pubitemid 44657858)
197. de Haij, S., M. R. Daha & C. van Kooten: Mechanism of steroid action in renal epithelial cells. Kidney Int, 65, 1577-88(2004) (Pubitemid 38591004)
198. Andrassy, M., A. Bierhaus, M. Hong, J. Sis, S. Schiekofer, P. M. Humper, J. Chen, M. Haap, W. Renn, E. Schleicher, H. U. Haring, K. Andrassy & P. P. Nawroth: Erythropoietin-mediated decrease of the redox-sensitive transcription factor NF-kappaB is inversely correlated with the hemoglobin level. Clin Nephrol, 58, 179-89(2002) (Pubitemid 34994044)
199. Spandou, E., I. Tsouchnikas, G. Karkavelas, E. Dounousi, C. Simeonidou, O. Guiba-Tziampiri & D. Tsakiris: Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant, 21, 330-6(2006) (Pubitemid 43159985)
200. Sarmiento, U. M., J. R. Perez, J. M. Becker & R. Narayanan: In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice. Antisense Res Dev, 4, 99-107(1994) (Pubitemid 24308378)
201. Cassiday, L. A. & L. J. Maher, 3rd: Yeast genetic selections to optimize RNA decoys for transcription factor NF-kappa B. Proc Natl Acad Sci U S A, 100, 3930-5(2003) (Pubitemid 36418134)
202. Vazquez, M. E., A. M. Caamano & J. L. Mascarenas: From transcription factors to designed sequence-specific DNA-binding peptides. Chem Soc Rev, 32, 338-49(2003) (Pubitemid 38353225)
203. Gearing, A. J.: Targeting toll-like receptors for drug development: a summary of commercial approaches. Immunol Cell Biol, 85, 490-4(2007) (Pubitemid 47367512)
204. Seki, E., S. de Minicis, C. H. Osterreicher, J. Kluwe, Y. Osawa, D. A. Brenner & R. F. Schwabe: TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med, 13, 1324-32(2007) (Pubitemid 350073596)
205. Arany, I.: Dual role of the activated epidermal growth factor receptor in renal tubular cells during stress. Kidney Int, 73, 5-7(2008) (Pubitemid 350273637)
206. Prakash, J., M. H. de Borst, A. M. van Loenen-Weemaes, M. Lacombe, F. Opdam, H. van Goor, D. K. Meijer, F. Moolenaar, K. Poelstra & R. J. Kok: Cellspecific Delivery of a Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor to Proximal Tubular Cells for the Treatment of Renal Fibrosis. Pharm Res (2008)
207. Khwaja, A., M. el Kossi, J. Floege & M. el Nahas: The management of CKD: a look into the future. Kidney Int, 72, 1316-23(2007) (Pubitemid 350126766)
208. Barnes, P. J. & M. Karin: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med, 336, 1066-71(1997) (Pubitemid 27163860)
209. Hayashi, R., H. Wada, K. Ito & I. M. Adcock: Effects of glucocorticoids on gene transcription. Eur J Pharmacol, 500, 51-62(2004) (Pubitemid 39303996)
210. Auwardt, R. B., S. J. Mudge, C. G. Chen & D. A. Power: Regulation of nuclear factor kappaB by corticosteroids in rat mesangial cells. J Am Soc Nephrol, 9, 1620-8(1998)
211. Wendt, T., Y. M. Zhang, A. Bierhaus, J. Kriegsmann, Y. Deng, R. Waldherr, T. Teske, T. Luther, R. Funfstuck, P. P. Nawroth & et al.: Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant, 10, 1820-8(1995)
212. Donnahoo, K. K., D. R. Meldrum, R. Shenkar, C. S. Chung, E. Abraham & A. H. Harken: Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol, 163, 1328-32(2000) (Pubitemid 30169434)
213. Huang, X. R., Y. G. Kim, S. Suga, M. Mazzaldi, S. J. Kivlighn, R. J. & H. Y. Lan: NF-kappaBactivation and IL-1 expression in experimental uric acid nephropathy. J Am Soc Nephrol 11, 490A (2000)
214. Muller, D. N., R. Dechend, E. M. Mervaala, J. K. Park, F. Schmidt, A. Fiebeler, J. Theuer, V. Breu, D. Ganten, H. Haller & F. C. Luft: NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension, 35, 193-201(2000) (Pubitemid 30054172)
215. Kim, H. J., K. W. Kim, B. P. Yu & H. Y. Chung: The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radic Biol Med, 28, 683-92(2000)
216. Khachigian, L. M., T. Collins & J. W. Fries: N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappa B expression in vivo. Am J Pathol, 151, 1225-9(1997) (Pubitemid 27479751)